Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
Guaraldi G, Malagoli A, Calcagno A, Mussi C, Celesia BM, Carli F, Piconi S, De Socio GV, Cattelan AM, Orofino G, Riva A, Focà E, Nozza S, Di Perri G. Guaraldi G, et al. Among authors: de socio gv. BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0. BMC Geriatr. 2018. PMID: 29678160 Free PMC article.
Ageing with HIV: a multidisciplinary review.
Calcagno A, Nozza S, Muss C, Celesia BM, Carli F, Piconi S, De Socio GV, Cattelan AM, Orofino G, Ripamonti D, Riva A, Di Perri G. Calcagno A, et al. Among authors: de socio gv. Infection. 2015 Oct;43(5):509-22. doi: 10.1007/s15010-015-0795-5. Epub 2015 May 19. Infection. 2015. PMID: 25987480 Review.
Erratum to: Ageing with HIV: a multidisciplinary review.
Calcagno A, Nozza S, Mussi C, Celesia BM, Carli F, Piconi S, De Socio GV, Cattelan AM, Orofino G, Ripamonti D, Riva A, Di Perri G. Calcagno A, et al. Among authors: de socio gv. Infection. 2015 Oct;43(5):627. doi: 10.1007/s15010-015-0808-4. Infection. 2015. PMID: 26104726 No abstract available.
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade.
Taramasso L, Bonfanti P, Ricci E, Maggi P, Orofino G, Squillace N, Menzaghi B, Madeddu G, Molteni C, Vichi F, Riguccini E, Saracino A, Santoro C, Guastavigna M, Francisci D, Di Biagio A, De Socio GV; CISAI study group. Taramasso L, et al. Among authors: de socio gv. HIV Med. 2022 Jan;23(1):70-79. doi: 10.1111/hiv.13165. Epub 2021 Sep 2. HIV Med. 2022. PMID: 34473897 Free article.
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study.
Taramasso L, De Vito A, Ricci ED, Orofino G, Squillace N, Menzaghi B, Molteni C, Gulminetti R, De Socio GV, Pellicanò GF, Sarchi E, Celesia BM, Calza L, Rusconi S, Valsecchi L, Martinelli CV, Cascio A, Maggi P, Vichi F, Angioni G, Guadagnino G, Cenderello G, Dentone C, Bandera A, Falasca K, Bonfanti P, Di Biagio A, Madeddu G; Behalf of the CISAI Study Group. Taramasso L, et al. Among authors: de socio gv, de vito a. AIDS Patient Care STDS. 2021 Sep;35(9):342-353. doi: 10.1089/apc.2021.0089. AIDS Patient Care STDS. 2021. PMID: 34524918
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals.
Taramasso L, Madeddu G, Ricci E, De Socio GV, Menzaghi B, Orofino G, Passerini S, Franzetti M, Maggi P, Dentone C, Martinelli C, Celesia BM, Penco G, Libertone R, Quirino T, Bonfanti P, Di Biagio A; CISAI Study Group. Taramasso L, et al. Among authors: de socio gv. Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12. Biomed Pharmacother. 2015. PMID: 25661363
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
Madeddu G, De Socio GV, Ricci E, Quirino T, Orofino G, Carenzi L, Franzetti M, Parruti G, Martinelli C, Vichi F, Penco G, Dentone C, Celesia BM, Maggi P, Libertone R, Bagella P, Di Biagio A, Bonfanti P; C.I.S.A.I. Group, Italy. Madeddu G, et al. Among authors: de socio gv. Int J Antimicrob Agents. 2015 Mar;45(3):289-94. doi: 10.1016/j.ijantimicag.2014.10.013. Epub 2014 Nov 13. Int J Antimicrob Agents. 2015. PMID: 25476452
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.
Bagella P, De Socio GV, Ricci E, Menzaghi B, Martinelli C, Squillace N, Maggi P, Orofino G, Calza L, Carenzi L, Celesia BM, Penco G, Di Biagio A, Valsecchi L, Vichi F, Colombo V, Parruti G, Dentone C, Falasca K, Bonfanti P, Madeddu G; C.I.S.A.I. Study Group, Italy. Bagella P, et al. Among authors: de socio gv. Infect Drug Resist. 2018 Apr 26;11:615-623. doi: 10.2147/IDR.S152090. eCollection 2018. Infect Drug Resist. 2018. PMID: 29731650 Free PMC article.
Low frequency of skin reactions in a cohort of patients on raltegravir.
Bonfanti P, Ricci E, Molteni C, De Socio GV, Rusconi S, Vichi F, Penco G, Antinori A, Cordier L, Maggi P, Celesia BM, Grosso C, Quirino T. Bonfanti P, et al. Among authors: de socio gv. J Antimicrob Chemother. 2012 Jul;67(7):1800-2. doi: 10.1093/jac/dks096. Epub 2012 Mar 22. J Antimicrob Chemother. 2012. PMID: 22441576 Free article. No abstract available.
130 results